TCL Archive NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending July 12, 2013
TCL Archive Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy. June 30, 2000
TCL Archive Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal December 16, 2011
TCL Archive AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them May 16, 1975
